157 related articles for article (PubMed ID: 18397265)
1. Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner.
Hartmann TN; Leick M; Ewers S; Diefenbacher A; Schraufstatter I; Honczarenko M; Burger M
Immunology; 2008 Oct; 125(2):252-62. PubMed ID: 18397265
[TBL] [Abstract][Full Text] [Related]
2. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.
Leick M; Catusse J; Follo M; Nibbs RJ; Hartmann TN; Veelken H; Burger M
Immunology; 2010 Apr; 129(4):536-46. PubMed ID: 20002784
[TBL] [Abstract][Full Text] [Related]
3. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
Catusse J; Leick M; Groch M; Clark DJ; Buchner MV; Zirlik K; Burger M
Mol Cancer; 2010 Nov; 9():297. PubMed ID: 21092185
[TBL] [Abstract][Full Text] [Related]
4. Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages.
Sato K; Kawasaki H; Nagayama H; Enomoto M; Morimoto C; Tadokoro K; Juji T; Takahashi TA
Int Immunol; 2001 Feb; 13(2):167-79. PubMed ID: 11157850
[TBL] [Abstract][Full Text] [Related]
5. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
6. The orphan G-protein-coupled receptor 75 signaling is activated by the chemokine CCL5.
Dedoni S; Campbell LA; Harvey BK; Avdoshina V; Mocchetti I
J Neurochem; 2018 Sep; 146(5):526-539. PubMed ID: 29772059
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes.
Hornung F; Scala G; Lenardo MJ
J Immunol; 2000 Jun; 164(12):6180-7. PubMed ID: 10843668
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A
Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304
[TBL] [Abstract][Full Text] [Related]
9. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
10. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
11. An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5.
Sato K; Kawasaki H; Morimoto C; Yamashima N; Matsuyama T
J Immunol; 2002 Jun; 168(12):6263-72. PubMed ID: 12055240
[TBL] [Abstract][Full Text] [Related]
12. The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis.
Chan O; Burke JD; Gao DF; Fish EN
J Biol Chem; 2012 Aug; 287(35):29406-16. PubMed ID: 22782897
[TBL] [Abstract][Full Text] [Related]
13. CRAM-A indicates IFN-γ-associated inflammatory response in breast cancer.
Sarmadi P; Tunali G; Esendagli-Yilmaz G; Yilmaz KB; Esendagli G
Mol Immunol; 2015 Dec; 68(2 Pt C):692-8. PubMed ID: 26563945
[TBL] [Abstract][Full Text] [Related]
14. Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta.
Kim MO; Suh HS; Brosnan CF; Lee SC
J Neurochem; 2004 Jul; 90(2):297-308. PubMed ID: 15228586
[TBL] [Abstract][Full Text] [Related]
15. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
16. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.
Struyf S; De Meester I; Scharpé S; Lenaerts JP; Menten P; Wang JM; Proost P; Van Damme J
Eur J Immunol; 1998 Apr; 28(4):1262-71. PubMed ID: 9565366
[TBL] [Abstract][Full Text] [Related]
17. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor.
Honczarenko M; Le Y; Glodek AM; Majka M; Campbell JJ; Ratajczak MZ; Silberstein LE
Blood; 2002 Oct; 100(7):2321-9. PubMed ID: 12239139
[TBL] [Abstract][Full Text] [Related]
18. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.
Imai T; Baba M; Nishimura M; Kakizaki M; Takagi S; Yoshie O
J Biol Chem; 1997 Jun; 272(23):15036-42. PubMed ID: 9169480
[TBL] [Abstract][Full Text] [Related]
19. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.
Sotsios Y; Whittaker GC; Westwick J; Ward SG
J Immunol; 1999 Dec; 163(11):5954-63. PubMed ID: 10570282
[TBL] [Abstract][Full Text] [Related]
20. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
